Insulet

Insulet Corporation Wins $452 Million in Trade Secret Lawsuit Against EOFlow, Marking Major Legal Victory

by

Boston, MA — Insulet Corporation, a major player in medical device manufacturing, recently secured a monumental legal victory in the U.S. District Court for the District of Massachusetts. The jury found that competitors EOFlow Co., Ltd. among others had illegally used Insulet’s closely guarded trade secrets, awarding the company a staggering total of $452 million in damages. This hefty sum consists of $170 million in compensatory damages meant to cover the loss incurred by Insulet, and an additional $282 million in punitive damages, reflecting the jury’s finding that EOFlow’s actions were both willful and malicious. … Read more

Federal Judge Keeps Core Allegations Alive in Insulet Corp. Trade Secrets Case Against South Korean Firm

by

Boston, MA – In a recent legal development, a federal judge in Massachusetts has decided not to dismiss certain allegations in a lawsuit filed by Insulet Corp. against a South Korean manufacturer of insulin pump patches. The core of the dispute revolves around Insulet Corp.’s allegations that the defendant unlawfully appropriated trade secrets. The court also determined that the timing of when the plaintiff’s federal trade secrets claim was initiated should be decided by a jury. Insulet Corp., a prominent player in the medical device industry, primarily known for its innovative insulin delivery systems, accuses … Read more